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Reply
To the Editor-We appreciate the comments of Eizirik [1] in
response to our article and the subsequent correspondence [2-
4]. He restates the hypothesis that occult cytokine profiles are
required to induce a high output of nitric oxide (NO) synthase
activity (iNOS) in human mononuclear phagocytes. He ob-
serves that the basal production of 7.1 pmol of NO/islet in un-
stimulated human islet cells is increased to 16.5 pmol by treat-
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ment with tumor necrosis factor-a (TNFa), to 23.7 pmol by
TNFa combined with interferon-v (IFN-')'), and to 37.4 pmol
by TNFa combined with IFN-')' and interleukin-l d (IL-l{j) [5].
Thus, he proposes that IL-l {j, by the way a secretory product of
macro phages (but not of islet cells) activated with lipopolysac-
charide, IFN-')', TNFa, bacteria, or a complete afferent loop of
cell-mediated immunity, could be essential for inducing iNOS
activity in human mononuclear phagocytes. Our experiments
[2] (table 1) tell otherwise.
Recently it was proposed that human mononuclear phago-
cytes can be induced to secrete NO by coculture with certain
tumor cells [6]. In these studies, however, no attempts were
made to control for an activation of iNOS in the tumor cells used
(that had a basal NOS activity if cultured without phagocytes)
by secretory products of macrophages such as IL-l{j or TNFa
Table 1. Comparison of nitrite (N02")secretion by macrophages from different human sources.
Cell source
(human)
Blood-derived
macrophages
Hepatoma cells
(HuH-7)
Lung carcinoma
ceIls (A 549/8)
Peritoneal
macrophages
Pretreatment for 48 h
IFN-')' + GM-CSF + TNFa*
Autologous sensitized lymphocytes + PPD + IL-2
108 heat-killed Listeria monocytogenes
108 heat-killed Moraxella catarrhalis
IFN-')' + LPS + IL-I + TNFa + HuH-7
IFN-')' + LPS + IL-I + TNFa
IFN-')' + TNFa
IFN-')' + IL-I + TNFa
N02"
(I-Lmol/I06 cells/day)
<0.1
<0.1
<0.1
<0.1
<0.1
<0.1
4.9 ± 1.5
<0.1
NOTE. Culture conditions are in [2J. Data are mean ± SE from triplicate experiments. IL-I, human recombi-
nant interleukin I-tt, 100 units/ml.; IFN, interferon; GM-CSF, granulocyte-macrophage colony-stimulating fac-
tor; TNF. tumor necrosis factor; PPD, purified protein derivative; LPS, lipopolysaccharide.
* Pretreatment for 12 days.
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during coculture. This control is essential in view of the respon-
siveness of NOS in human tumor cell lines to such stimuli [7]
(table I).
We therefore conclude that in human mononuclear phago-
cytes, iNOS is not induced by IL-I {j. In addition, in clear distinc-
tion to other human cell types, no convincing evidence has been
provided for iNOS in human macrophages thus far.
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High Rate of Reactivation of Human Herpesvirus 6 in
Children with Dengue Hemorrhagic Fever
Colleagues-In 1986, a new herpesvirus, now designated as
human herpesvirus 6 (HHV-6), was isolated from patients with
Iymphoproliferative disorders [I] and was recognized to be the
causative agent of exanthem subitum in 1988 [2]. It is now be-
lieved that HHV -6 persists in the host after primary infection
and can be reactivated later in life. By characterization of iso-
lates obtained worldwide from various diseases, HHV-6 is now
classified into two variants: HHV-6A and HHV-6B [3].
Dengue fever is a common childhood disease in tropical
countries. Although dengue virus infection usually results in
mild disease, sometimes infection by this virus can result in a
severe disease such as dengue hemorrhagic fever (DHF) and
dengue shock syndrome [4]. Alterations in the immune system
ofDHF patients are likely since there is extensive damage to the
lymphoid tissue of various organs and some depression of the
bone marrow elements [5]. In the present study, we investigated
HHV -6 reactivation in DHF patients.
The study included 30 patients with suspected DHF who
were admitted to the children's ward of Charoenkrung Pra-
charak Hospital. Patients were 3-13 years old (3-5,26%; 6-10,
48%;and 11-13, 26%). These patients were classified into DHF
grade I or II according to their typical clinical manifestations of
the following: fever, hemorrhagic manifestations including a pos-
itive tourniquet test and some bleeding phenomena, thrombo-
cytopenia, and hemoconcentration. During the course ofillness,
Informed consent was obtained from parents ofall patients.
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they did not receive blood transfusion or steroid therapy. For
virologic and serologic studies, peripheral blood (-- 5 mL) was
drawn into heparinized medium during the acute phase on the
first day ofhospital admission and again during the convalescent
phase 2-3 weeks after the onset of disease. Heparinized blood
samples from both phases were separated into plasma and pe-
ripheral blood mononuclear cells (PBMC) using Ficoll-Paque
(Pharmacia, Piscataway, NJ) gradient centrifugation. PBMC
were divided into two parts (--2 X 106 cells each) for virus
isolation and detection of HHV-6 DNA. Antibody to HHV-6
was determined by immunofluorescence antibody (IFA) testing
as described [2]. The titer ofantibody was expressed as the high-
est dilution yielding detectable immunofluorescence. Antibody
to dengue virus was determined by the hemagglutination inhibi-
tion (HAl) test with dengue virus type 2 used as antigen. At least
a fourfold increase in antibody titer in plasma between the acute
and convalescent phases or an antibody titer of> I: 1280 in the
acute phase was considered positive for a second dengue virus
infection. The method for detection ofHHV-6 DNA in PBMC
by polymerase chain reaction (PCR) was described previously
[6]. For virus isolation, PBMC were cultured in RPMI 1640
supplemented with 10%fetal bovine serum, 0.1 unit ofrecomb i-
nant human interleukin-2 (provided by Takeda Chemical In-
dustries, Osaka, Japan) and phytohemagglutinin (5 mg/mL;
Honen, Tokyo) at 37°C as described [2]. The medium was
changed weekly, and cells were observed for cytopathic effect
(CPE) for 2 weeks. Isolates were classified by IFA test as HHV-
6A or -6B by use ofmonoclonal antibodies OHV-I and OHV-3;
OHV-I reacted with both variants, whereas OHV-3 reacted only
with HHV-6B [7]. The Wilcoxon signed rank test was used to
compare antibody titers to HHV-6 in DHF patients.
All patients had DHF with typical symptoms: fever, hemor-
rhagic manifestations, thrombocytopenia, and hemoconcentra-
tion. Spontaneous bleeding in some patients developed only in
the tourniquet test (grade I) but others had hemorrhages, such as
petechiae, maculopapular rash, gum bleeding, epistaxis, and
black vomiting (grade II). Symptoms such as restlessness, hepa-
tomegaly, abnormal reflex, vomiting, injected pharynx, and
cough also appeared in some cases. All 30 suspected patients
